γδ T Cells Enhance Autoimmunity by Restraining Regulatory T Cell Responses via an Interleukin-23-Dependent Mechanism  by Petermann, Franziska et al.
Immunity
Articlegd T Cells Enhance Autoimmunity
by Restraining Regulatory T Cell Responses
via an Interleukin-23-Dependent Mechanism
Franziska Petermann,1 Veit Rothhammer,1 Malte C. Claussen,1 Jan D. Haas,2 Lorena Riol Blanco,3 Sylvia Heink,1
Immo Prinz,2 Bernhard Hemmer,1 Vijay K. Kuchroo,4 Mohamed Oukka,5,* and Thomas Korn1,*
1Klinikum rechts der Isar, Department of Neurology, Technical University Munich, Ismaninger Str. 22, 81675 Munich, Germany
2Hannover Medical School, Institute for Immunology, 30625 Hannover, Germany
3Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
4Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
5Seattle Children’s Hospital, Center for Immunity and Immunotherapies, University of Washington School of Medicine, 1900 Ninth Avenue,
M/S C9S-7, Seattle, WA 98101, USA
*Correspondence: moukka@u.washington.edu (M.O.), korn@lrz.tum.de (T.K.)
DOI 10.1016/j.immuni.2010.08.013SUMMARY
Mice that lack interleukin-23 (IL-23) are resistant to
T cell-mediated autoimmunity. Although IL-23 is a
maturation factor for T helper 17 (Th17) cells, a subset
of gd T cells expresses the IL-23 receptor (IL-23R)
constitutively. Using IL-23R reporter mice, we
showed that gd T cells were the first cells to respond
to IL-23 during experimental autoimmune encepha-
lomyelitis (EAE). Although gd T cells produced Th17
cell-associated cytokines in response to IL-23, their
major function was to prevent the development of
regulatory T (Treg) cell responses. IL-23-activated
gd T cells rendered ab effector T cells refractory to
the suppressive activity of Treg cells and also pre-
vented the conversion of conventional T cells into
Foxp3+ Treg cells in vivo. Thus, IL-23, which by itself
has no direct effect on Treg cells, is able to disarm
Treg cell responses and promote antigen-specific
effector T cell responses via activating gd T cells.
INTRODUCTION
gd T cells bear a T cell receptor (TCR) composed of rearranged g
and d chains instead of the conventional ab heterodimeric TCR.
Whereas gd T cells constitute the majority of immune cells in
certain niches associated with epithelial surfaces, only 1% of
T cells in secondary lymphoid tissue are gd T cells. Most of the
gd T cells in secondary lymphoid organs are positive for the non-
canonical TCR-g1 or TCR-g4 chains (Hayday, 2000; Hayday and
Pennington, 2007). Ligand recognition by gd TCRs appears to be
dispensable for selection of gd T cells in the adult thymus.
Whether it is required for the selection of gd T cells in embryonic
thymus is not clear (Itohara et al., 1993; Lewis et al., 2006; Xiong
et al., 2004). Little is known about the antigenic repertoire and
restriction elements of the gd-TCR. gd T cell development is
apparently neither affected in major histocompatibility complex
(MHC) class II-deficient nor in b2microglobulin-deficient animalsIm(Bigby et al., 1993; Correa et al., 1992). In secondary and tertiary
lymphoid tissue, gd T cells are able to respond directly to path-
ogen-associatedmolecular patterns and to cytokines in the local
milieu in the absence of cognate TCR ligands. Thus, gd T cells
have many properties of cells of the innate immune system. gd
T cells appear early during immune responses and efficiently
produce inflammatory cytokines such as interferon-g (IFN-g)
and tumor necrosis factor (TNF) (Duhindan et al., 1997), but
have also been reported to secrete interleukin-10 (IL-10) (Rho-
des et al., 2008). The ability of gd T cells to produce IL-17 has
been appreciated only recently and the role of IL-17 producing
gd T cells has been evaluated in various models of infection
and autoimmunity (Jensen et al., 2008; Martin et al., 2009; Ribot
et al., 2009; Sutton et al., 2009).
IL-23 is a major pathogenic factor in organ specific autoimmu-
nity and chronic inflammation (Cua et al., 2003; Murphy et al.,
2003; Yen et al., 2006), given that IL-23 is a maturation and
potentially also a growth factor for pathogenic IL-17 producing
ab T cells, so-called Th17 cells (Korn et al., 2009). Yet, other
ab T cell-extrinsic functions of IL-23 have been proposed
because first, the IL-23 receptor (IL-23R) is expressed on
a variety of non-ab T cells (Awasthi et al., 2009) and, second,
IL-23 is also relevant in models of chronic inflammation that
were independent of ab T cells (Buonocore et al., 2010; Uhlig
et al., 2006). However, the function of IL-23 in vivo is still not
completely understood. To identify the cell types responding to
IL-23 during experimental autoimmune encephalomyelitis
(EAE) in vivo, we generated a mutant mouse, in which an internal
ribosome entry site (IRES)-green fluorescent protein (GFP)-
cassette was introduced into the endogenous Il23r gene
(Awasthi et al., 2009). As a result of this ‘‘knockin’’ strategy,
heterozygous Il23r+/ animals can be used as reporter mice to
identify IL-23R-positive cells on the basis of GFP expression
while they are still fully responsive to IL-23 because of one intact
Il23r allele. Homozygous Il23r/mice are unresponsive to IL-23
due to two mutated Il23r alleles.
Here, we found that in the steady state, gd T cells express
constitutively high amounts of IL-23R and respond early and
vigorously to IL-23. IL-23 drives the expansion and accumulation
of IL23R+ gd T cells and the secretion of IL-17, IL-21, and IL-22munity 33, 351–363, September 24, 2010 ª2010 Elsevier Inc. 351
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IL-23R+ gd T Cells Inhibit Treg Cell Responsesby gd T cells. Yet, the most crucial effector function of IL-23-acti-
vated gd T cells in an inflammatory environment is not the
production of Th17 cell-associated cytokines, but their ability
to antagonize Treg cell-mediated suppression of ab T cells.
This offers an explanation why the presence of Treg cells at sites
of inflammation is not sufficient to suppress ab T cell-mediated
immunopathology during highly inflammatory stages of organ-
specific autoimmunity.
RESULTS
IL-23R Expressing gd T Cells Are a Functionally Distinct
Subset of gd T Cells
Naive ab T cells lack the receptor for IL-23 (Mangan et al., 2006),
whereas the IL-23R is highly expressed in marked fractions of gd
T cells in lymph nodes and spleen of unmanipulated mice (Awas-
thi et al., 2009). Therefore, we first tested the responsiveness of
purified CD4-CD8- gd T cells from Il23r/ and Il23r+/ littermates
to IL-12 and IL-23, respectively. Both ab T cells and gd T cells
produced IFN-g in response to IL-12 and as expected, their
IFN-g production was not affected by lack of IL-23R expression
(Figure 1A). In contrast, IL-23 induced the secretion of IL-17 in
bulk Il23r+/ CD4+ ab T cells and purified gd T cells (Figure 1A).
gd T cells responded to IL-23 even in the absence of TCR
stimulation (data not shown). Neither ab T cells nor gd T cells
from Il23r/ mice produced IL-17 in response to IL-23
(Figure 1A). Because gd T cells have the phenotype of activated
lymphocytes, we compared their cytokine secretion capacity
with the cytokine response of antigen-experienced CD4+CD44+
ab T cells. On a per cell basis, gd T cells were more potent
producers of IFN-g and IL-17 than CD44+ ab T cells in response
to IL-12 and IL-23, respectively (Figure 1B). Unlike IL-12, IL-23
had an additional effect on its target population in that it also
increased the fraction of IL-23R expressing gd T cells by
promoting the proliferation of IL-23R+ but not IL-23R gd
T cells (Figures 1C and 1D). In order to correlate the production
of IFN-g and IL-17 with the IL-23R status in individual gd T cells,
we purified gd T cells from the lymph nodes of Il23r+/ mice and
determined the production of IFN-g and IL-17 upon ex vivo
stimulation with PMA plus ionomycin. All IFN-g producing gd
T cells were IL-23R, whereas IL-17 was exclusively produced
by IL-23R+ gd T cells. The IL-23RIFN-g+ and IL-23R+IL-17+
phenotypes segregated with the expression of NK1.1 and C-C
motif receptor (CCR)6, respectively (Figure S1 available online).
Thus, CCR6 defines the population of IL-23R+IL-17+ gd T cells
whereas NK1.1 is a marker for IL-23R-IFN-g+ gd T cells (see
also (Haas et al., 2009)).
The frequency of Th17 cells in the CD44+ compartment of
activated or memory T cells is diminished in Il6/mice because
IL-6 together with transforming growth factor-b (TGF-b) is essen-
tial in generating Th17 cell precursors. TGF-b and IL-6 are also
required to induce retinoic acid-related orphan receptor-gt
(ROR-gt) and IL-23R in ab T cells (Zhou et al., 2007). Thus, we
wondered how IL-6 deficiency affected the frequency of gd
T cells in secondary lymphoid tissues. Although the overall
fraction of gd T cells in Il6/ mice was not diminished and was
even slightly higher in spleen (Figure S1), CCR6+ gd T cells
were significantly decreased and NK1.1+ gd T cells were
increased in IL-6-deficient mice as compared with wild-type352 Immunity 33, 351–363, September 24, 2010 ª2010 Elsevier Inc.animals. The decreased fraction of CCR6+ gd T cells in Il6/
mice correlated with a lower percentage of IL-23R+ gd T cells
and IL-17 producers both in lymph node and splenic Il6/ gd
T cells (Figure S1). Together, these data suggest that the
development and homeostasis of IL-23R+ gd T cells may be
modulated by IL-6.
IL-23R+ gd T Cells Expand upon Immunization
with MOG35-55 plus CFA and Accumulate
in the Central Nervous System
Next, we wanted to investigate how IL-23R+ gd T cells re-
sponded during an autoimmune reaction in vivo (Figure 2A).
Although gd T cells constitute the minority of T cells in secondary
lymphoid tissues, 7% of gd T cells as compared to only 0.3% of
ab T cells in lymph nodes of naive mice were positive for IL-23R
(Figure S2). Upon sensitization with MOG35-55 plus CFA, a new
population of IL-23RlowCD44+CD25low cells emerged within the
ab T cells compartment probably representing Th17 cells that
were primed in an antigen-specific manner (Figure S2). Notably,
the fraction of gd T cells in draining lymph nodes also expanded
and now, one-fifth or more of these gd T cells expressed IL-23R.
As a result, IL-23R+ gd T cells (which were also CCR6+TCR-g4+)
were significantly enriched in the draining lymph nodes of
immunized animals (Figure S2).
In order to evaluate the relative contribution of IL-23R- and
IL-23R+ gd T cells to disease development, we followed their
dynamics in various lymphoid compartments and in the CNS
and compared them with the population dynamics of Th17 cells
and Foxp3+ Treg cells. Upon immunization with MOG35-55 plus
CFA, Th17 cells (IL-23R+ ab T cells) expanded in the draining
lymph nodes and accumulated in the spleen prior to clinical signs
of disease (Figures 2B–2D). When the animals became sick,
Th17 cells appeared in the CNS. The inverse population
dynamics of Th17 cells in spleen versus CNS suggested that
the splenic pool of Th17 cells drained into the target tissue.
IL-23R+ gd T cells but also IL-23R gd T cells in the spleen of
immunized mice increased until the peak of disease and
declined during recovery from EAE. However, IL-23R+ gd
T cells never outnumbered IL-23R gd T cells in the peripheral
immune compartment (Figures 2B–2D). In contrast in the CNS,
IL-23R+ gd T cells accumulated in an almost exclusive manner.
Here, the fraction of IL-23R+ gd T cells within the CD3+ T cell infil-
trate increased 8-fold (Figure 2C) and the absolute number of
IL-23R+ gd T cells expanded 20-fold during development of
clinical signs of disease (Figure 2D). Consistent with the prepon-
derance of IL-23R+ over IL-23R gd T cells, gd T cells contributed
substantially to the IL-17 production, but not the IFN-g produc-
tion in the CNS (Figure S2). During recovery, the IL-23R+ gd
T cells population in the CNS contracted to numbers observed
in naive mice. Thus, changes of the IL-23R+ gd T cells population
in the CNS reflected closely the clinical course of EAE and the
state of inflammation in the target tissue. Interestingly, Foxp3+
Treg cells were present in the CNS at the onset of clinical signs
of disease, but expanded to high numbers only after the attrition
of IL-23R+ gd T cells (Figures 2C and 2D). Moreover, Foxp3+ Treg
cells appeared to control effector functions of ab T cells only
after the disappearance of gd T cells. Thus, these data sug-
gested a functional relationship between the dynamics of gd
T cells and Foxp3+ Treg cells in inflamed tissue.
0
1,000
2,000
3,000
4,000
5,000
No
 c
yt
ok
in
es
IL
-
23
IL
-
12
IL
-
12
 
pl
u
s 
IL
-
23
IF
N
-γ
 
[pg
/m
l]
0
200
400
600
800
1,000
No
 c
yt
ok
in
es
IL
-
23
IL
-
12
IL
-
12
 
pl
u
s 
IL
-
23
IL
-1
7 
[pg
/m
l]
0
7,500
15,000
22,500
30,000
No
 c
yt
ok
in
es
IL
-
23
IL
-
12
IL
-1
2 
pl
us
 
IL
-2
3
IF
N
-γ
 
[pg
/m
l]
0
2,500
5,000
7,500
10,000
No
 c
yt
ok
in
es
IL
-
23
IL
-
12
IL
-
12
 
pl
u
s 
IL
-
23
IL
-1
7 
[pg
/m
l]
IL23r 
+/-
IL23r 
-/-
αβ T cells γδ T cells
αβ T cells γδ T cells
A B
C
N
on
e
IL
-1
2
IL
-2
3
N
on
e
IL
-1
2
IL
-2
3
0
4,000
8,000
12,000
CD44+ αβ T cells γδ T cells
P<0.02
N
on
e
IL
-1
2
IL
-2
3
N
on
e
IL
-1
2
IL
-2
30
200
400
600 P<0.002
IL
-1
7 
[pg
/m
l]
CD44+ αβ T cells γδ T cells
D
No cytokines IL-12 IL-23
PKH26
IL
-2
3R
 (G
FP
)
3.1 3.6 21.1
IL-23R (GFP)
SS
C
No cytokines IL-12 IL-23
25.45.86.7
IL23r 
+/-
IL23r 
-/-
IF
N
-γ
 
[pg
/m
l]
Figure 1. gd T Cells Produce High Amounts of IFN-g and IL-17 in Response to IL-12 and IL-23, Respectively
(A and B) CD4CD8 gd T cells and bulk CD4+ ab T cells (A) or flow cytometrically purified CD4+CD44+ ab T cells (B) were isolated from Il23r/mice or Il23r+/
littermates. Cells were stimulated for 72 hr with anti-CD3 plus anti-CD28 coated beads (A) or for 24 hr with plate-bound monoclonal antibodies to CD3 (0.5 mg/ml)
and CD28 (0.25 mg/ml) (B) in the presence of the indicated cytokines. IFN-g and IL-17 production were determined by ELISA. Amount of cytokines produced in
triplicate wells ± SD.
(C) After in vitro stimulation with anti-CD3 plus anti-CD28 coated beads, Il23r+/ gd T cells were analyzed for IL-23R (GFP) expression. Numbers indicate
percentages within the gd-TCR gate.
(D) Il23r+/ gd T cells isolated from naive Il23r+/ reporter mice were labeled with PKH26 and stimulated with anti-CD3 plus anti-CD28 beads in the presence of
the indicated cytokines. After 3 days, dilution of PKH26 was measured in the gate of blasting gd T cells by flow cytometry. Numbers indicate percentages of
proliferating IL-23R+ gd T cells. See also Figure S1.
Immunity
IL-23R+ gd T Cells Inhibit Treg Cell Responsesgd T Cells Prevent the Induction of Foxp3 in CD4+ T Cells
in an IL-23-Dependent Manner
Themassive accumulation of IL-23R+ gd T cells in the CNS at the
peak of inflammation suggested that IL-23 was a dominant
factor in the local milieu. We wondered whether IL-23 had any
additional effect on local gd T cells in addition to the induction
of IL-17 because in this disease phase, large amounts of IL-17
are already produced by Th17 cells. Furthermore, we noticed
an accelerated increase in the Foxp3+ Treg cell population in
the CNS only after the disappearance of IL-23R+ gd T cells.ImThus, in an initial in vitro screening approach, we activated gd
T cells with IL-23 and tested the effect of their cell culture super-
natant on the conversion of conventional CD4+ T cells into
Foxp3+ Treg cells. Naive Foxp3 T cells (CD4+CD44) were puri-
fied from Foxp3gfp.KI mice and polyclonally stimulated in the
presence of TGF-b. Similarly to recombinant IL-6 (Bettelli et al.,
2006) and IL-21 (Korn et al., 2007a) native but not boiled super-
natant from IL-23-activated gd T cells inhibited the TGF-b-driven
conversion of naive Foxp3 ab T cells into Foxp3-expressing
T cells (Figures 3A and 3B). The most efficient (heat-sensitive)munity 33, 351–363, September 24, 2010 ª2010 Elsevier Inc. 353
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Figure 2. IL-23R+ gd T Cells Accumulate in the CNS at the Peak of EAE and Rapidly Contract during Recovery
(A) Il23r+/ andFoxp3gfp.KImicewere immunizedwithMOG35-55 plusCFA.Both strains behave likewild-typeC57BL/6mice and a representative disease course is
shown (meanclinical score+SEM,n=5).Draining lymphnode (LN)cells, splenocytes, andmononuclear cells fromtheCNSwerepreparedatdifferent stagesofEAE.
Immunity
IL-23R+ gd T Cells Inhibit Treg Cell Responses
354 Immunity 33, 351–363, September 24, 2010 ª2010 Elsevier Inc.
Immunity
IL-23R+ gd T Cells Inhibit Treg Cell Responsesfactors that suppress TGF-b-driven induction of Foxp3 in naive
T cells are IL-4, IL-6, IL-21, and IL-27 (Awasthi et al., 2007;
Bettelli et al., 2006; Dardalhon et al., 2008; Korn et al., 2007a;
Stumhofer et al., 2007). However, IL-4, IL-6, and IL-27 were
not produced by IL-23-activated gd T cells. In contrast, IL-21
was produced by IL-23-activated gd T cells (Figure 3C). Yet,
neutralizing IL-21 or IL-6 with blocking antibodies did not
diminish the capacity of supernatant from IL-23-activated gd
T cells to suppress TGF-b-driven expression of Foxp3
(Figure 3D). In addition, IL-6 or IL-21 together with TGF-b are
strong inducers of IL-17 in naive ab T cells (Korn et al., 2007a),
whereas IL-23-activated gd T cell supernatant together with
TGF-b failed to induce IL-17 in naive responder T cells
(Figure S3). The gene expression program that was induced in
ab T cells in the presence of TGF-b plus IL-23-activated gd
T cell supernatant included T-bet and IL-12Rb2, as well as
IL-22 (Figure S3). Thus, we conclude that exposure of gd
T cells to IL-23 creates a cytokine milieu that directly acts on
the intrinsic development of ab T cells by inhibiting their
conversion into Foxp3+ Treg cells.
gd T Cells Inhibit Treg Cell Responses In Vivo
and Promote Inflammation
To evaluate the impact of IL-23-driven functions of gd T cells
in vivo, we adoptively transferred CD3+ T cells derived from
wild-type mice (CD90.1) that were left untreated or depleted
of gd T cells into Il23r/ hosts. The recipient mice were then
immunized with MOG35-55 plus CFA and the activation status
of the donor T cells was investigated after 2 weeks. In this
scenario, sensitization of donor CD4+ T cells must have
occurred either in the absence or in the presence of (donor-
derived) IL-23-responsive gd T cells in vivo. When priming of
T cells occurred in the presence of IL-23R+ gd T cells, the
fraction of Foxp3+ T cells in the donor T cell population was
always reduced as compared to priming without IL-23-respon-
sive gd T cells (Figures 4A and 4B). Thus, the presence of IL-23-
responsive gd T cells appeared to restrain Treg cell expansion.
In order to test whether gd T cells also inhibited the conversion
of conventional T cells into Foxp3+ Treg cells in vivo (as we
found in vitro), we injected Foxp3 MOG35-55 specific TCR
transgenic (2D2) indicator T cells purified from 2D2 3
Foxp3gfp.KI mice into Rag1/ host mice in the absence of or
with cotransfer of wild-type gd T cells and immunized the recip-
ient mice with MOG35-55 plus CFA. Because CFA induces high
amounts of IL-6 that would disguise any gd T cell-mediated
effects on inhibiting the conversion of conventional T cells into
Foxp3+ Treg cells, we administered a monoclonal antibody to
IL-6R. Under these conditions, we observed a measurable
MOG35-55-induced conversion of conventional 2D2 cells into
Foxp3+ 2D2 T cells (Figure 4C). However, this conversion was
abrogated by gd T cells (Figures 4C and 4D), confirming our(B) IL-23R (GFP) expression in gd T cells (gd-TCR+) and ab T cells (CD3+gd-TCR
recovery.
(C) Percentages of IL-23R- gd T cells, IL-23R+ gd T cells, Treg cells (CD4+Foxp
compartments and the CNS; mean percentages + SD.
(D) Absolute numbers of IL-23R+ ab T cells, IL-23R, and IL-23R+ gd T cells as
obtained in the flow cytometric analysis and assessment of total live mononuc
the CNS correspond to Th17 cells. See also Figure S2.
Imin vitro finding that activated gd T cells are efficient in suppress-
ing the conversion of conventional T cells into Foxp3+ Treg
cells independently of IL-6. Taken together, these data suggest
that gd T cells can modulate the commitment of ab T cells to
effector versus regulatory T cell lineages in the peripheral
immune compartment.
gd T Cells Contribute to the Development of EAE
by Restraining Treg Cell Responses
Treg cells do not express IL-23R (Figure S4) and IL-23 alone had
no impact on the efficacy of naturally occurring Foxp3+ Treg cells
to suppress polyclonal ab T cell responses in vitro (Figure 5A).
Only in the presence of gd T cells was IL-23 able to reverse the
suppression of effector T cells by Treg cells (Figure 5A). Notably,
cell-free supernatant of IL-23-activated gd T cells was equally
efficient in abrogating Treg cell-mediated suppression of poly-
clonal ab T cell responses (Figure 5B). Because in an antigen-
presenting cell (APC)-free system gd T cell-derived supernatant
abrogated the proliferative arrest of effector T cells, but did not
enhance proliferation of Foxp3+ Treg cells (Figure 5C), we
hypothesize that the biological activity of gd T cell supernatant
might render responder T cells resistant to Treg cell-mediated
suppression, reminiscent of the effect of IL-6 (Pasare and
Medzhitov, 2003).
To determine the functional relevance of gd T cell mediated
inhibition of both Treg cell conversion and suppression of ab
T cell responses by naturally occurring Treg cells in a disease
model, we revisited the Treg cell compartment in Tcrd/
mice. Unmanipulated Tcrd/ mice harbored higher fractions
of Foxp3+ Treg cells in secondary lymphoid organs as compared
to age-matched controls housed in the same facility (Figure 6A).
It has previously been shown that CD103+ Treg cells accumulate
in inflamed tissues (Huehn et al., 2004) and in the CNS of EAE
mice, the vast majority of MOG35-55-IA
b tetramer+ Foxp3+ Treg
cells are CD103+ (Korn et al., 2007b). Upon immunization with
MOG35-55 plus CFA, the percentage of CD103
+ Treg cells in
draining lymph nodes and spleen was increased in Tcrd/
mice as compared with wild-type controls (Figure 6B). In
contrast, the CD4+ T cell compartment—in particular in the
spleen—contained lower fractions of IL-17 and IFN-g producers
in MOG35-55-sensitized Tcrd
/ mice than in wild-type controls
(Figure 6B). Together, these data suggested that antigen-driven
Treg cell responses were enhanced in Tcrd/ mice. The devel-
opment of EAE in Tcrd/mice is attenuated (Figure 6C), and we
assumed that the relative protection from disease in Tcrd/
mice is due to the very strong Treg cell response in these
animals. In order to test this hypothesis, we depleted Treg cells
in Tcrd/mice with amonoclonal antibody to CD25 and studied
whether this restored full susceptibility to EAE. In contrast to
control-treated Tcrd/ animals, Treg cell-depleted Tcrd/
mice were no longer protected from EAE and developed severe) was analyzed by flow cytometry at the onset and peak of disease and during
3+), and IL-23R+ ab T cells within the CD3+ T cell gate in various lymphoid
well as CD4+Foxp3+ Treg cells were calculated on the basis of percentages
lear cells in a trypan blue exclusion analysis. Note that IL-23R+ ab T cells in
munity 33, 351–363, September 24, 2010 ª2010 Elsevier Inc. 355
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Figure 3. Cell-Free Supernatant from IL-23-Activated gd T Cells Abrogates the TGF-b-Driven Induction of Foxp3 in Conventional T Cells
Independently of IL-6 and IL-21
(A and B) Flow cytometrically purified naive conventional T cells (CD4+CD44Foxp3) from Foxp3gfp.KI mice were activated with antibodies to CD3 and CD28
in the presence of different cytokines or gd T cell culture supernatants as indicated. After 3 days, Foxp3 (GFP) expression was determined by flow cytometry
(histograms in A and B; numbers indicate percentages).
(C) Cytokine profile of gd T cells. gd T cells were purified by magnetic bead sorting and directly used for preparation of RNA or further stimulated with anti-CD3
plus anti-CD28 coated beads for 4 days without or in the presence of IL-23 followed by isolation of RNA. Expression of cytokines was determined by quantitative
PCR as described in Supplemental Experimental Procedures. Flow cytometrically sorted naive conventional T cells (CD4+CD44Foxp3) were analyzed for
comparison.
(D) Neutralization of IL-6 or IL-21: Naive conventional T cells were stimulated with anti-CD3 plus anti-CD28 and the indicated cytokines or supernatants from gd
T cells in the presence of goat IgG or blocking antibodies to IL-6 or IL-21. After 3 days, induction of Foxp3 (GFP) was determined by flow cytometry (histograms
in D; numbers indicate percentages). See also Figure S3.
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Figure 4. gd T Cells Inhibit Treg Cell
Responses In Vivo
(A and B) CD3+ T cells derived from congenic wild-
type mice (CD90.1) were left untreated or depleted
of gd T cells followed by intravenous transfer
(5 3 106) into Il23r/ hosts and immunization
with MOG35-55 plus CFA one day later. As shown
in (A), after in vivo sensitization, donor cells were
reisolated from draining lymph nodes and
analyzed for expression of gd-TCR and Foxp3 by
flow cytometry. (B) shows the fraction of Foxp3+
Treg cells within the CD4+ T cell compartment of
substituted cells (CD90.1).
(C and D) gd T cells inhibit the conversion of
conventional T cells into Foxp3+ Treg cells
in vivo: Foxp3 2D2 responder T cells were sorted
by flow cytometry from 2D2 3 Foxp3gfp.KI mice
and transferred i.v. into Rag1/ recipients without
or with cotransfer of gd T cells from wild-type
donors. Host mice were immunized with
MOG35-55 plus CFA and treated with a monoclonal
antibody to IL-6R i.p. for prevention of CFA-
induced IL-6 from overriding gd T cell effects on
the conversion of conventional T cells into
Foxp3+ Treg cells. On day 15 after immunization,
2D2 cells were reisolated from lymph nodes,
spleen, and CNS, and the frequency of MOG35-55
specific Foxp3 (GFP)+ Treg cells was measured
by flow cytometry (C). The rate of 2D2 T cells con-
verted into antigen specific Foxp3+ Treg cells is
depicted for the various lymphoid compartments
and the CNS (D); mean + SD, nR 3.
Immunity
IL-23R+ gd T Cells Inhibit Treg Cell ResponsesEAE identical to wild-type mice (Figure 6C and Table 1). At the
peak of disease, Tcrd/ mice tended to have higher fractions
of Treg cells in the inflamed CNS than wild-type mice
(Figure 6D). Although the percentages of IL-17 producers,
IFN-g producers, and TNF producers among CD4+Foxp3
T cells that were recovered from the CNS parenchyma were
not different between wild-type and Tcrd/ mice, the latter
had significantly decreased absolute numbers of cytokine
producing CD4+Foxp3 effector T cells in the CNS (Figure 6E).
Treg cell depletion restored the absolute amount of cytokine
producing effector T cells in the CNS of Tcrd/ mice to wild-
type numbers (Figure 6E). Accordingly, the disease phenotype
in Treg cell-depleted Tcrd/ was similar to wild-type animals.
However, Foxp3+ Treg cells recovered faster in Treg cell-
depleted Tcrd/ mice than in Treg cell-depleted wild-type
animals, which developed a fulminant disease with marked
mortality (Figure 6E and Table 1). Together, these data confirm
that the priming of autoantigen-specific ab T cells is not impaired
in a cell-intrinsic manner in Tcrd/ mice. Rather, the relative
protection from EAE in these animals is mediated by an
enhanced Treg cell response. Thus, reminiscent of IL-6-deficient
mice, the absence of gd T cells appears to favor the generation
and expansion of Treg cells, which then successfully control
antigen-specific activation of ab T cells.ImDISCUSSION
In this study, we have identified a mechanism by which gd T cells
enable the initiation of adaptive immune responses: gd T cells
suppressed early Treg cell responses in an IL-23 dependent
manner. gd T cells expressed high amounts of IL-23R and
responded to IL-23 by secretion of IL-17, IL-21, and IL-22.
However, IL-23-activated gd T cells also exerted a marked inhib-
itory effect both on Treg cell-mediated suppression of effector
T cell responses and on conversion of conventional T cells into
Foxp3-expressing Treg cells. Although IL-23 had no direct
impact on the generation and function of antigen-specific Treg
cells, products of IL-23-activated gd T cells restrained the
generation and function of Treg cells independently of Th17
cell-associated cytokines. By this mechanism, IL-23-activated
gd T cells shifted the balance between Treg cells and conven-
tional ab T cells in favor of effector T helper cells. These results
may explain in part why IL-23 holds a key position in initiating au-
toreactive ab T cell responses in vivo.
Hypotheses on the pathogenic mechanism of IL-23 include
expansion of Th17 memory cells (Aggarwal et al., 2003;
McGeachy et al., 2009) and maturation of Th17 cells by
increasing their capacity to secrete IL-17 (Veldhoen et al.,
2006) and by shutting down other cytokine genes such as Il10munity 33, 351–363, September 24, 2010 ª2010 Elsevier Inc. 357
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Figure 5. IL-23 Reverses Treg Cell-Mediated Suppression of ab T Cells Only in the Presence of gd T Cells
(A) CD4+Foxp3+ Treg cells isolated by flow cytometry sorting from the spleens and lymph nodes of naive Foxp3gfp.KI mice were tested for their suppressive
capacity in the presence of gd T cells in vitro. A fixed number of naive responder T cells (CD4+Foxp3) was cultured 1:1 with Treg cells, gd T cells, and a
monoclonal antibody to CD3 in the presence of syngeneic irradiated and gd T cell-depleted splenocytes as APCs. IL-23 was added at a concentration of
25 ng/ml as indicated.
(B) In an analogous assay, Treg cell-mediated suppression of responder T cells was tested in the presence of IL-23 or cell culture supernatants of gd T cells
that had been stimulated for 4 days with anti-CD3 plus anti-CD28 coated beads without or in the presence of IL-23. Proliferation was determined by 3[H]thymidine
incorporation (mean + SD of triplicate cultures). In (B), the proliferation was normalized to the unsuppressed condition (absence of Treg cells) within each
condition. The unsuppressed proliferation of responder T cells was 10,600 ± 1,410 cpm and 20,300 ± 1,330 cpm in the presence of regular and IL-23-activated
gd T cell supernatant, respectively.
(C) Dye dilution assay for differential assessment of responder cell and Treg cell proliferation. CD4+CD44-Foxp3 responder T cells and CD4+Foxp3+ Treg
cellswere sortedby flowcytometry fromFoxp3gfp.KImice, loadedwith the reddyePKH26, and cultured in thepresence of anti-CD3plus anti-CD28-coatedbeads
and gd T cell-derived supernatants as indicated. After 3 days, the percentages of PKH26dim cells were determined separately within the Foxp3 and Foxp3 (GFP)+
T cell gates as a measure of the proliferative response. Representative histograms out of three independent experiments are shown. See also Figure S4.
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IL-23R+ gd T Cells Inhibit Treg Cell Responses(McGeachy et al., 2007). IL-23might endow ab T cells with ence-
phalotropism although it remains to be determined whether this
includes the induction of molecular addressins (Gyu¨lve´szi et al.,
2009). Finally, IL-23 was proposed to exert functions that are not
targeted to T cells but are independent of conventional T cells358 Immunity 33, 351–363, September 24, 2010 ª2010 Elsevier Inc.(Buonocore et al., 2010; Uhlig et al., 2006). Blockade of IL-23
is effective in early phases of autoimmune reactions. However,
IL-23 has also been suggested to play a role in the late plasticity
of committed Th17 cells in that it resurrects the transcription of
IFN-g in the absence of TGF-b (Lee et al., 2009). Moreover,
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Figure 6. gd T Cells Promote EAE by Antagonizing Treg Cell Function
(A) Tcrd/mice have increased frequencies of Foxp3+ Treg cells. Lymph node cells and splenocytes were isolated from naive wild-type mice and age-matched
Tcrd/ animals bred in the same facility. The percentage of Foxp3+ Treg cells in the compartment of CD4+ T cells was determined by flow cytometry.
(B) On day 6 after sensitization with MOG35-55 plus CFA, draining lymph node cells and splenocytes were isolated and stained for Foxp3 or intracellular cytokines.
The percentages of Foxp3+CD103+ Treg cells, IL-17+Foxp3, and IFN-g+Foxp3 effector T cells within the compartment of conventional CD4+ T cells are
depicted (n = 4).
(C–E) Treg cell depletion in Tcrd/ mice restores full susceptibility to EAE. Wild-type or Tcrd/ mice were treated with control IgG1 or with a monoclonal
antibody to CD25 (PC61) for Treg cell depletion followed by immunization with MOG35-55 plus CFA. Means of clinical scores (+SEM, n = 5) are presented in
(C). Pooled EAE scores from two independent experiments are shown. As shown in (D), at the peak of disease (d18), mononuclear cells from the CNS were
recovered and tested for expression of Foxp3 and intracellular cytokines within the population of CD4+ ab T cells. Fractions of Foxp3+ cells and cytokine+ cells
within the CNS CD4+ T cell population (D) and absolute numbers (E) of Foxp3+ cells or IL-17+Foxp3, IFN-g+Foxp3, and TNF+Foxp3 CD4+ effector T cells are
depicted; mean + SD, nR 4.
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Table 1. Summary of EAE Clinical Parameters
Wild-Type
(IgG)
Wild-Type
(anti-CD25)
Tcrd/
(IgG)
Tcrd/
(anti-CD25)
Incidence 7/9 = 78% 5/5 = 100% 3/9 = 33% 11/11 = 100%
Mortality 0/9 = 0% 1/5 = 20% 0/9 = 0% 0/11 = 0%
Day of onset 14.3 ± 0.70 13.8 ± 0.20 14.0 ± 1.0 14.9 ± 0.4
Maximum
EAE score
2.2 ± 0.46 3.6 ± 0.40 0.7 ± 0.34a 2.7 ± 0.22b
Cumulative results from two independent experiments are shown in
this table.
a Compared to wild-type (IgG) mice: p < 0.03; calculated by Mann-
Whitney U rank sum test.
b Compared to Tcrd/ (IgG) mice: p < 0.0009; calculated by Mann-
Whitney U rank sum test.
Immunity
IL-23R+ gd T Cells Inhibit Treg Cell ResponsesEAE is transient and self-limiting when the availability of IL-23 is
not sustained (Veldhoen et al., 2006). Together, these observa-
tions are consistent with the idea that IL-23 acts as a major path-
ogenic factor in autoimmunity. Yet, it is not just a theoretical
concern that every single step in the pathogenic cascade of ab
T cell-driven autoimmunity is feasible in the absence of IL-23 (Ja¨-
ger et al., 2009), but still Il23p19/ mice and Il23r/ mice are
completely resistant to actively induced EAE (Awasthi et al.,
2009; Cua et al., 2003).
Upon exposure to IL-23, gd T cells produce IL-17 irrespective
of further gd TCR stimuli. IL-17 production by gd T cells is depen-
dent on expression of IL-23R. In contrast to naive ab T cells in
which TGF-b plus IL-6 is required to induce IL-17 production,
gd T cells respond directly to IL-23. Consistent with previous
results, IL-6 is no longer necessary to induce the production of
IL-17 in those gd T cells that already express ROR-gt (Lochner
et al., 2008). However, precursor frequencies of CCR6+IL-23R+
gd T cells are reduced in lymph nodes and spleen of Il6/
mice, suggesting that IL-6 is still required for the commitment
of gd T cells to express IL-23R. This concept is not mutually
exclusive with the finding that the ability of IL-17 production by
gd T cells may already be acquired in the thymus triggered by
either lack of TCR ligand engagement (Jensen et al., 2008) or
failure to upregulate CD27 (Ribot et al., 2009).
The property of swift production of IL-17 and IL-22 by IL-23R+
gd T cells fits in the concept that these effector cytokines are
associated with immunity at epithelial surfaces where gd
T cells are abundant and where IL-23 may be playing an impor-
tant part in guiding immune responses (Aujla et al., 2008; Becher
et al., 2003; Ouyang et al., 2008; Ye et al., 2001). However, the
importance of IL-17 and IL-22 has been questioned for autoim-
mune neuroinflammation because Il17a/, Il21/, and Il22/
mice are not protected from EAE (Haak et al., 2009; Kreymborg
et al., 2007; Sonderegger et al., 2008). Thus, individual effector
cytokines might not play a nonredundant role in the pathogenic
potential of Th17 cells.
Our data suggest that IL-23R+ gd T cells provide a more
general means to enhance immune responses in that they
suppress Treg cell responses. It has recently been shown
that a high frequency of gd T cells precedes the generation of
MOG35-55-specific ab T cells in the draining lymph nodes until
day 4 after immunization with MOG35-55 plus CFA (Wohler
et al., 2009). Indeed, we here demonstrate that IL-23R+ gd360 Immunity 33, 351–363, September 24, 2010 ª2010 Elsevier Inc.T cells also accumulate in the CNS simultaneously to the full
display of ab T cell-driven immunopathology. More importantly,
the IL-23R+ gd T cells population in the CNS rapidly contracts
prior to clinical recovery. Only then the Treg cell response is
able to control inflammation in the CNS. We propose that gd
T cells, when activated by IL-23, create a cytokine milieu in the
vicinity of ab T cells and Treg cells that initiates inflammation
by restraining the generation and function of Treg cells. It
remains to be determined whether a putative soluble factor
produced by activated gd T cells directly inhibits Treg cells or
strengthens the resistance of ab T effector cells to Treg cell-
mediated suppression (e. g. by promoting the production of
IL-2). Paracrine factor(s) from IL-23-activated gd T cells offer
an explanation why Treg cells—even though present in abun-
dance—fail to curtail tissue damage at early stages of an immune
response. It has always been a major question why Treg cells at
various sites of inflammation (CNS, synovial tissue, and intes-
tines) fail to be effective in the local milieu at the onset of inflam-
mation (Korn et al., 2007b). IL-6 inhibits Treg cell-mediated
suppression (Pasare and Medzhitov, 2003) and the de novo
induction of Foxp3 in conventional T cells whereas—together
with TGF-b—IL-6 promotes the proliferation of Th17 cells.
However, IL-23-activated gd T cells did not produce IL-6. Cell-
free supernatant from IL-23-activated gd T cells inhibited both
Treg cell-mediated suppression of conventional ab T cells and
TGF-b-driven induction of Foxp3 in naive CD4+ T cells in APC-
free systems. A number of cytokines including IL-4, IL-21, and
IL-27 (but not IL-17 and IL-22) have been identified to inhibit
TGF-b-driven conversion of conventional T cells into Foxp3+
Treg cells (Awasthi et al., 2007; Dardalhon et al., 2008; Korn
et al., 2007a). Unlike IL-4 and IL-27, which are not produced
by IL-23-stimulated gd T cells, IL-21 is strongly induced in gd
T cells upon exposure with IL-23. Yet, neutralization of IL-21
did not reverse the suppression of Foxp3 induction by gd T cell
supernatants. We conclude that presumably by inducing
a heat-sensitive mediator or a panel of humoral factors with
paracrine activity, IL-23 prompts gd T cells to block TGF-b-
driven Foxp3 induction in ab T cells and to restrain Treg cell
function in vitro and in vivo.
gd T cells responses can be essential and nonredundant in
host defense at epithelial surfaces. This has been shown for
infection with Nocardia and Listeria whose early control most
likely involves direct effector functions of gd T cells (King et al.,
1999; Riol-Blanco et al., 2010; Skeen and Ziegler, 1993). gd
T cells have also been implicated in the pathogenesis of autoim-
mune tissue inflammation (Odyniec et al., 2004; Rajan et al.,
1998). For example, gd T cells were detected inmultiple sclerosis
(MS) lesions and appeared clonally expanded on the basis of
restricted usage of TCR variable chain segment (V) g9 (Wucherp-
fennig et al., 1992). Furthermore, the fraction of gd T cells in
circulating blood, most of which are Vg9 positive (Poggi et al.,
2007), is a predictor of disease activity in MS patients as mea-
sured by magnetic resonance imaging (Rinaldi et al., 2006).
Thus, it is likely that noncanonical gd T cells from secondary
lymphoid organs are involved in promoting tissue inflammation
in human autoimmunity. Various effector functions of gd T cells
have been proposed. For example, gd T cells interact directly
with B cells and promote Ig class switching (Wen et al., 1996).
gd T cells also interact with ab T cells, to which they can present
Immunity
IL-23R+ gd T Cells Inhibit Treg Cell Responsesantigen but which can also be a target of direct killing by gd
T cells (Brandes et al., 2005; Vincent et al., 1996). The role
of IL-23 for gd T cell-mediated effects in vivo has only been
discussed in terms of inducing Th17 cell-associated cytokines
in gd T cells, which might license APCs to activate ab T cells
(Sutton et al., 2009). However, we did not observe a priming
defect of encephalitogenic ab T cells in Tcrd/ mice per se,
although we clearly identified enhanced Treg cell responses in
the absence of gd T cells.
Thus, we propose an unexpected mechanism to explain how
noncanonical Vg4+ gd T cells that express IL-23Rmight enhance
autoimmune tissue inflammation: IL-23 that is exclusively ex-
pressed under inflammatory conditions can reverse Treg cell-
mediated suppression by activating gd T cells. IL-23 arms gd
T cells to restrain Treg cell responses in a locally constrained
manner, releasing nascent adaptive ab T cell responses from
inhibition. As a result, those body compartments that contain
high frequencies of gd T cells or are easily accessible to gd
T cells with noncanonical gd TCRs, like neuroectodermal tissue,
might be particularly susceptible to IL-23-driven inflammation.EXPERIMENTAL PROCEDURES
Animals and Induction of EAE
Foxp3gfp.KI-mice and IL-23Rgfp.KI mice have been described previously
(Awasthi et al., 2009; Bettelli et al., 2006; Korn et al., 2007b). CD90.1 congenic
C57BL/6 mice, Tcrd/ mice, and IL-6 deficient mice were obtained from
Jackson Laboratories. EAE was induced by subcutaneous immunization of
mice with 100 ml of an emulsion containing 100 mg of MOG35-55 peptide
(MEVGWYRSPFSRVVHLYRNGK) and 250 mg ofM. tuberculosisH37Ra (Difco,
Detroit, MI) in Freund’s adjuvant oil (CFA) plus intraperitoneal (i.p.) injection of
200 ng pertussis toxin (Fluka) on day 0 and day 2. For Treg cell depletion,
animals were injected i.p. with 500 mg of monoclonal antibody to CD25
(PC61) on day 5 and day 3 prior to immunization. For adoptive transfer
experiments, 5 3 106 purified CD3+ T cells or gd T cell-depleted CD3+
T cells from congenic mice (CD90.1) were transferred intravenously (i.v.) into
Il23r/ recipients 1 day prior to immunization. In some experiments, we
injected 3.5 3 106 naive (CD4+CD44Foxp3) T cells purified from 2D2 3
Foxp3gfp.KI mice into Rag1/ host recipients in the absence of or with
cotransfer of 0.5 3 106 wild-type gd T cells 2 days prior to immunization with
MOG35-55 plus CFA. Recipient mice received i.p. injections of a monoclonal
antibody to IL-6R (15A7, 0.5 mg) on days 1, 3, 5, and 9 after cell transfer.
Clinical signs of EAE were assessed as reported (Korn et al., 2007b). Animals
were kept in a specific pathogen-free facility at the Technical University
Munich, and all experiments were carried out in accordance with the guide-
lines prescribed by the Bavarian state authorities (Az 55.2-1-54-2531-88-08).T Cell Differentiation
Cells were cultured in Dulbecco’s Modified Eagle medium (DMEM) with 10%
fetal calf serum (FCS) supplemented with 5 3 105 M b-mercaptoethanol,
1 mM sodium pyruvate, nonessential amino acids, L-glutamine, 100 U/ml
penicillin, and 100 mg/ml streptomycin. For in vitro T cell differentiation,
CD4+ T cells were purified from naive splenocytes and lymph node cells with
anti-CD4+ magnetic beads (Miltenyi), and gd T cells were purified from CD4
flow through by use of the gd T cell two-step magnetic bead-purification kit
from Miltenyi. For obtaining naive T cells, CD4+ T cells were sorted into
CD4+CD44Foxp3 T cells by fluorescence activated cell sorting. For some
experiments, gd T cells or CD4+CD44+ activated or memory T cells were puri-
fied by fluorescence activated cell sorting. T cells were stimulated for 3 days
with plate-bound antibody to CD3 (145-2C11, 0.5 mg/ml) and antibody to
CD28 (PV-1, 0.25 mg/ml) or by anti-CD3 plus anti-CD28 coated beads
(Miltenyi). Recombinant cytokines were added to the differentiation cultures
as indicated: human TGF-b1 (3 ng/ml), mouse IL-6 (30 ng/ml), mouse IL-21Im(100 ng/ml), mouse IL-22 (200 ng/ml), mouse IL-27 (50 ng/ml), mouse IL-12
(25 ng/ml), or mouse IL-23 (25 ng/ml, all R&D Systems).
Treg Cell Suppression and Conversion Assays
25.000 CD4+Foxp3 T cells were cocultured with 25,000 Treg cells and
200,000 irradiated (3.000 rad) syngeneic splenic gd T cell-depleted APCs
per well in the presence of an antibody tomouse CD3 (1 mg/ml) for 72 hr. During
the last 16 hr, cells were pulsed with 1 mCi of 3[H]thymidine (PerkinElmer) and
then harvested on glass fiber filters and analyzed with incorporated 3[H]thymi-
dine in a b-counter (1450 Microbeta, Trilux, PerkinElmer). Where indicated,
25,000 gd T cells were cocultured in addition to the responder plus Treg cell
mixture. Where indicated, IL-23 (R&D Systems) was added to the cultures at
a concentration of 25 ng/ml. In some experiments, supernatants from gd
T cells were used. Supernatants were collected from gd T cells that were
stimulated for 3 days with anti-CD3 plus anti-CD28 coated beads in the
absence or presence of IL-23 (25 ng/ml). Besides measuring proliferation by
3[H]thymidine incorporation, a dye dilution approach was used. Here,
responder T cells and Treg cells were labeled with PKH26 (Sigma-Aldrich) in
accordance with the manufacturer’s instructions.
For determining conversion of conventional T cells into Foxp3+ Treg cells,
naive T cells from Foxp3gfp.KI mice were purified by flow cytometric sorting
(CD4+CD44Foxp3). Naive T cells were stimulated with plate-bound
monoclonal antibodies to mouse CD3 (145-2C11, 2 mg/ml) and CD28 (PV-1,
4 mg/ml) for 3 days in the presence of the indicated cytokines: human
TGF-b1 (5 ng/ml), mouse IL-6 (37,5 ng/ml), mouse IL-21 (100 ng/ml), mouse
IL-23 (25 ng/ml, all R&D Systems), or gd T cell-derived supernatants as
described. Where indicated, control goat IgG or blocking antibodies to IL-6
or IL-21 (R&D systems) were added at a concentration of 12.5 mg/ml. Foxp3
(GFP) induction and—after additional stimulation with PMA plus ionomycin
in the presence of monensin—intracellular cytokines were assessed by flow
cytometry.
Statistical Analysis
Statistical evaluations of cell frequency measurements and proliferation
data were performed with the unpaired Student’s t test. For comparison of
clinical EAE scores, the Mann-Whitney U rank sum test was used. Two-tailed
p values < 0.05 were considered significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.immuni.2010.08.013.
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